L Danhauser

685 total citations
18 papers, 576 citations indexed

About

L Danhauser is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, L Danhauser has authored 18 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in L Danhauser's work include Colorectal Cancer Treatments and Studies (6 papers), Biochemical and Molecular Research (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). L Danhauser is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Biochemical and Molecular Research (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). L Danhauser collaborates with scholars based in United States and Sweden. L Danhauser's co-authors include William Plunkett, Michael J. Keating, Youcef M. Rustum, Stephen Iacoboni, Jan Liliemark, F. R. Strebel, L. Clifton Stephens, Tetsuya Kaneko, Elihu H. Estey and J. M. C. Bull and has published in prestigious journals such as Journal of Clinical Oncology, Biochimica et Biophysica Acta (BBA) - General Subjects and Cancer Chemotherapy and Pharmacology.

In The Last Decade

L Danhauser

18 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Danhauser United States 12 271 138 125 121 114 18 576
L. J. Goutas United States 7 277 1.0× 149 1.1× 46 0.4× 148 1.2× 80 0.7× 7 549
Dominic Wall Australia 16 316 1.2× 39 0.3× 67 0.5× 340 2.8× 130 1.1× 39 729
C Wheeler United States 12 209 0.8× 86 0.6× 60 0.5× 343 2.8× 203 1.8× 23 686
Feng Meng United States 10 182 0.7× 39 0.3× 146 1.2× 155 1.3× 182 1.6× 16 531
Russell Karp United States 11 374 1.4× 30 0.2× 174 1.4× 196 1.6× 53 0.5× 16 711
Taina Jaatinen Finland 17 332 1.2× 35 0.3× 142 1.1× 105 0.9× 185 1.6× 28 750
Djoke van Gosliga Netherlands 13 570 2.1× 31 0.2× 88 0.7× 155 1.3× 237 2.1× 18 978
Eduard H. Panosyan United States 14 418 1.5× 470 3.4× 161 1.3× 175 1.4× 70 0.6× 31 1.0k
G Pizzorno United States 13 301 1.1× 73 0.5× 21 0.2× 199 1.6× 45 0.4× 19 558
Ingrid Jakobsen Falk Sweden 16 294 1.1× 40 0.3× 61 0.5× 202 1.7× 113 1.0× 37 882

Countries citing papers authored by L Danhauser

Since Specialization
Citations

This map shows the geographic impact of L Danhauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Danhauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Danhauser more than expected).

Fields of papers citing papers by L Danhauser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Danhauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Danhauser. The network helps show where L Danhauser may publish in the future.

Co-authorship network of co-authors of L Danhauser

This figure shows the co-authorship network connecting the top 25 collaborators of L Danhauser. A scholar is included among the top collaborators of L Danhauser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Danhauser. L Danhauser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Matsuda, Hikaru, et al.. (1996). Apoptosis and necrosis occurring during different stages of primary and metastatic tumor growth of a rat mammary adenocarcinoma.. PubMed. 16(3A). 1117–21. 11 indexed citations
3.
Klostergaard, Jim, et al.. (1995). Multi-chemothermoimmunotherapy for human colon adenocarcinoma in vitro. Cancer Chemotherapy and Pharmacology. 37(3). 235–241. 3 indexed citations
4.
Stephens, L. Clifton, Masato Makino, Tetsuya Kaneko, et al.. (1995). Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats.. PubMed. 55(22). 5459–64. 116 indexed citations
5.
Stephens, L. Clifton, et al.. (1994). Apoptosis in normal tissues induced by 5-fluorouracil: comparison between bolus injection and prolonged infusion.. PubMed. 14(4A). 1489–92. 19 indexed citations
6.
Makino, Masato, Tetsuya Kaneko, L. Clifton Stephens, et al.. (1994). Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats.. PubMed. 54(8). 2223–7. 28 indexed citations
7.
Danhauser, L, et al.. (1993). Phase I and plasma pharmacokinetic study of infusional fluorouracil combined with recombinant interferon alfa-2b in patients with advanced cancer.. Journal of Clinical Oncology. 11(4). 751–761. 31 indexed citations
8.
Gandhi, Varsha, L Danhauser, & William Plunkett. (1987). Separation of 1-β-d-arabinofuranosylcytosine 5′-triphosphate and 9-β-d-arabinofuranosyl-2-fluoroadenine 5′-triphosphate in human leukemia cells by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 413. 293–299. 35 indexed citations
9.
Danhauser, L, William Plunkett, Jan Liliemark, et al.. (1987). Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemia.. PubMed. 1(9). 638–43. 20 indexed citations
10.
Danhauser, L, William Plunkett, Michael J. Keating, & Fernando Cabanillas. (1986). 9-?-D-Arabinofuranosyl-2-fluoroadenine 5?-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphoma. Cancer Chemotherapy and Pharmacology. 18(2). 145–52. 81 indexed citations
11.
Plunkett, William, Stephen Iacoboni, Elihu H. Estey, et al.. (1985). Pharmacologically directed ara-C therapy for refractory leukemia.. PubMed. 12(2 Suppl 3). 20–30. 127 indexed citations
12.
Danhauser, L, Robert Heimer, & Ed Cadman. (1985). Lack of enhanced cytotoxicity of cultured L1210 cells using folinic acid in combination with sequential methotrexate and fluorouracil. Cancer Chemotherapy and Pharmacology. 15(3). 214–9. 8 indexed citations
13.
Danhauser, L & Youcef M. Rustum. (1985). Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.. PubMed. 45(5). 2002–7. 3 indexed citations
14.
Danhauser, L & Youcef M. Rustum. (1984). Chemotherapeutic Efficacy of 5-Fluorouracil with Concurrent Thymidine Infusion against Transplantable Colon Tumors in Rodents. PubMed. 1(4). 269–282. 3 indexed citations
15.
McCormick, P. Aiden, L Danhauser, Youcef M. Rustum, & John F. Bertram. (1983). Changes in ribo- and deoxyribonucleoside triphosphate pools within the cell cycle of a synchronized moused fibroblast cell line. Biochimica et Biophysica Acta (BBA) - General Subjects. 756(1). 36–40. 22 indexed citations
16.
Danhauser, L, et al.. (1981). Determinants of response to antimetabolites and their modulation by normal purine and pyrimidine metabolites.. PubMed. 65 Suppl 3. 73–82. 7 indexed citations
17.
Danhauser, L & Youcef M. Rustum. (1980). Effect of thymidine on the toxicity, antitumor activity, and metabolism of 1-beta-D-arabinofuranosylcytosine in rats bearing a chemically induced colon carcinoma.. PubMed. 40(4). 1274–80. 38 indexed citations
18.
Rustum, Y M, et al.. (1979). Selectivity of action of 5-FU: biochemical basis.. PubMed. 66(1). 43–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026